The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis

Objective & Hypothesis:Purpose: To determine the value of Anti-CCP as predictor for disease activity in rheumatoid arthritis assessed by DAS-28, and to find the effect of smoking on disease activity in rheumatoid arthritis.

📊

Key Findings & Data:Materials and Methods: One hundred patients with rheumatoid arthritis involved in this study, consisted of 88 female and 12 male who fulfilled the 2010 ACR-EULAR classification criteria for rheumatoid arthritis attending the rheumatology department in general hospital, or attended the center of rheumatology and rehabilitation in sulaimani city, for 6 months ( from October, 2012 to March, 2013).

💡

Conclusion & Impact:Smokers demonstrated a more active and severe disease activity compared to non-smokers.

🔬Design:Research Article

📍Scope:2010 Verileri

⚙️Variables:Anti-CCP · DAS-28 · Eklem İltihabı

Abstract

Purpose: To determine the value of Anti-CCP as predictor for disease activity in rheumatoid arthritis assessed by DAS-28, and to find the effect of smoking on disease activity in rheumatoid arthritis. Materials and Methods: One hundred patients with rheumatoid arthritis involved in this study, consisted of 88 female and 12 male who fulfilled the 2010 ACR-EULAR classification criteria for rheumatoid arthritis attending the rheumatology department in general hospital, or attended the center of rheumatology and rehabilitation in sulaimani city, for 6 months ( from October, 2012 to March, 2013). Thorough Demographic information of patients was recorded through history of age, sex, and history of smoking, disease duration, physical evaluation according to DAS-28. and serological test for RF and Anti-CCP. Results: There was highly significant association between DAS-28 and Anti-CCP value (p =0.0001). there was no significant correlation between DAS-28 and RF (p= 0.252),According to smoking there was highly significant association between smoking with Anti-CCP value and DAS-28 (p=0.003- 0.0001) respectively while there was no significant association between smoking and RF(p=0.15). Conclusion: A highly significant correlation was found between Anti-CCP value and disease activity in rheumatoid arthritis, smoker patients had higher value of Anti-CCP compared to non-smoker patients. Smokers demonstrated a more active and severe disease activity compared to non-smokers.

Özet

Amaç: DAS-28 ile belirlenen eklem iltihabında hastalığın aktivitesi için belirleyici olan Anti-CCP değerinin saptanması ve eklem iltihabının hastalık aktivitesinde sigara kullanımının etkisini belirlemektir. Materyal ve Method: 6 ay boyunca (2012 Ekim- 2013 Mart) Süleymaniye kentinde bulunan rehabilitasyon ve romatoloji merkezinde bulunmuş olan veya tam teşekküllü hastanenin romatoloji bölümünde bulunan, 2010 ACR-EULAR eklem iltihabı sınıflandırma kurallarına göre belirlenmiş, 88"i kadın 12"si erkek olmak üzere toplam 100 eklem iltihabı hastası çalışmaya dahil edildi. Hastaların yaş, cinsiyet, sigara kullanımı öyküsü, hastalık süreci, DAS-28"e göre fiziksel değerlendirmesi ve Anti-CCP ve RF için serolojik test sonuçları gibi kapsamlı demografik bilgileri kaydedildi. Bulgular: DAS-28 ile Anti-CCP değeri arasında oldukça anlamlı bir fark bulundu. (P değeri= 0,0001). DAS-28 ile RF değeri arasında bir fark bulunamadı (p= 0,252). Sigara kullanım durumuna göre; sigara içimi ile Anti-CCP değeri (p = 0,003) ve DAS-28 (p =0,0001) arasında oldukça anlamlı bir fark bulundu. Ancak; sigara içimi ile RF arasında anlamlı bir fark bulunamadı (p=0,15). Sonuç: Eklem iltihabında hastalık aktivitesi ile Anti-CCP değeri arasında oldukça önemli bir fark bulundu ayrıca sigara içen hastalar içmeyenlere nazaran daha yüksek Anti-CCP değerine sahiptiler. Sigara içenlerde ise içmeyenlere gore daha şiddetli ve aktif hastalık aktivitesi gözlendi.

Keywords

Anti-CCP DAS-28 Eklem İltihabı RF Rheumatoid arthritis RF.

🔖

Cite This Article

MERZA, R. R., TOFİQ, D. M., RADHİ, N. N., KHAN, H. A. E. K. (2014). The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis. Cukurova Medical Journal, Cilt: 39 - Sayı: 4, 0. https://ajindex.com/articles/56923

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (6)

Lee DM, Weinblatt ME. Rheumatoid Arthritis. Lancet. 2001;358:903–11.
Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five Rheumatoid Arthritis patients studied over nine years. Arthritis Rheum. 1984;27:864–72. Goodson N. Coronary artery disease and Rheumatoid Arthritis. CurrOpinRheumatol. 2002;14:115–20.
Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L: A gene–environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive Rheumatoid Arthritis. Arthritis Rheum. 2004;50:3085-92. Linn-Rasker SP, van der Helm-van Mil AHM, van Gaalen FA, Kloppenburg M, De Vries R, le Cessie S, Breedveld FC, Toes REM, Huizinga TWJ: Smoking is a risk factor for Anti-ccp antibodies only in RA patients that carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2005, in press. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B: Prediction of radiological outcome in early Rheumatoid Arthritis in clinical practice: role of antibodies to citrullinated peptides (Anti-ccp). Ann Rheum Dis. 2004;63:1090-5.
Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the Rheumatoid Arthritis-associated HLADRB1*0401 MHC class II molecule. J Immunol. 2003;171:538-41.
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR: A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of Rheumatoid Arthritis. Arthritis Res Ther 2004, 6:R303-R308. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38–46.
Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL et al. Autoantibodies to cyclic citrullinated peptides predict progression to Rheumatoid Arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50:709–15. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al. Antibodies against cyclic citrullinated peptide and IgA Rheumatoid factor predict the development of Rheumatoid Arthritis. Arthritis Rheum. 2003;48:2741– Klippel J